๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model

โœ Scribed by Craig E. Grossman; Stephen Pickup; Amy Durham; E. Paul Wileyto; Mary E. Putt; Theresa M. Busch


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
634 KB
Volume
43
Category
Article
ISSN
0196-8092

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background and Objective: Photodynamic therapy (PDT) of thoracic malignancies involving the pleural surfaces is an active area of clinical investigation. The present report aims to characterize a model for PDT of disseminated non-small cell lung carcinoma (NSCLC) grown orthotopically in nude mice, and to evaluate the effect of PDT on tumor and normal tissues. Study Design: H460 human NSCLC cells were injected percutaneously into the thoracic cavity of nude mice. HPPH-PDT (1 mg/kg, 24 hours) was performed via the interstitial delivery (150 mW/cm) of 661 nm light to the thoracic cavity at fluences of 25-200 J/cm. Results: H460 tumors exhibited exponential growth within the thoracic cavity consisting of diffuse, gross nodular disease within 9 days after intrathoracic injection. Tumor volume, measured by magnetic resonance imaging (MRI), was highly correlated with the aggregate tumor mass extracted from the corresponding animal. Intrathoracic PDT at fluences of !50 J/cm produced significant decreases in tumor burden as compared to untreated controls, however, mortality increased with rising fluence. Accordingly, 50 J/cm was selected for MRI studies to measure intra-animal PDT effects. Tumor distribution favored the ventral (vs. dorsal), caudal (vs. cranial), and right (vs. left) sides of the thoracic cavity by MRI; PDT did not change this spatial pattern despite an overall effect on tumor burden. Histopathology revealed edema and fibrin deposition within the pulmonary interstitium and alveoli of the PDTtreated thoracic cavity, as well as occasional evidence of vascular disruption. Prominent neutrophil infiltration with a concomitant decline in the lymphocyte compartment was also noted in the lung parenchyma within 24 hours after PDT. Conclusion: HPPH-PDT of an orthotopic model of disseminated NSCLC is both feasible and effective using intracavitary light delivery. We establish this animal model, together with the treatment and monitoring approaches, as novel and valuable methods for the pre-clinical investigation of intrathoracic PDT of disseminated pleural malignancies.


๐Ÿ“œ SIMILAR VOLUMES


Incorporation of photodynamic therapy as
โœ Patrick Ross Jr.; John Grecula; Tanios Bekaii-Saab; Miguel Villalona-Calero; Gre ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 273 KB

## Background and objectives: Incorporation of photodynamic therapy (pdt) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (nsclc) is explored. ## Study design/materials and methods: We present a retrospective review of 41

Long-Term survival of patients treated w
โœ Luigi Corti; Lamberto Toniolo; Caterina Boso; Flavio Colaut; Davide Fiore; Pier- ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB

## Abstract ## Purpose The role of photodynamic therapy (PDT) in the treatment of small cancers has been established in several clinical studies. Here, we report on the efficacy of PDT for early inoperable or recurrent nonโ€smallโ€cell lung cancer (NSCLC). ## Methods and Materials From June 1989 t

Human endostatin inhibits growth of huma
โœ Arnd Steffen Boehle; Roland Kurdow; Maren Schulze; Ursula Kliche; Bence Sipos; K ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 261 KB ๐Ÿ‘ 1 views

Overall prognosis in human NSCLC remains poor. Antiangiogenic treatment has become a promising concept for the treatment of solid malignancies. Our purpose was to evaluate the efficacy of recombinant HSENDO for the treatment of human NSCLC in an orthotopic murine xenotransplantation model. The effic

Chromogranin A gene expression in non-sm
โœ Abbona, Giancarlo; Papotti, Mauro; Viberti, Laura; Macr??, Luigia; Stella, Anna; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 2 views

Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA an

The 17-1A antigen is expressed on primar
โœ Bernward Passlick; Wulf Sienel; Rita Seen-Hibler; Werner Wรถckel; Olaf Thetter; K ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 294 KB ๐Ÿ‘ 1 views

In view of the high incidence of early distant tumor relapses in apparently completely resected (R0, M0) non-small cell lung cancer (NSCLC), there is a need for an adjuvant therapy. Considering the low tumor burden in these patients, an adjuvant therapy with monoclonal antibodies (i.e., the 17-1A MA